Butorphanol Injection

22 September 2008

Products Affected - Description

Butorphanol injection, Apotex
2 mg/mL 1-mL vial (NDC 60505-0659-00) - discontinued
2 mg/mL 10-mL vial (NDC 60505-0660-00) - discontinued
1 mg/mL 1-mL vial (NDC 60505-0658-00) - discontinued

Reason for the Shortage

Butorphanol products from Apotex and Bedford in the 2 mg/mL, 1-mL vial presentation are on back order. These companies cannot provide a reason for the shortage.

Estimated Resupply Dates

• Apotex has discontinued all presentations but will continue to ship remaining stock.
• Bedford and Hospira have all presentations available.

Related Shortages

• Alfentanil Injection— Resolved
• Choline Magnesium Trisalicylate
• Codeine Phosphate Oral Solution— No Longer Available
• Diazepam Injection— Resolved
• Fentanyl Transdermal System Patch— Resolved
• Hydrocodone Tablets
• Hydromorphone Hydrochloride Injection
• Indomethacin Capsules— Resolved
• Meperidine— Resolved
• Meperidine / Promethazine— No Longer Available
• Methadone Hydrochloride Injection— Resolved
• Methadone Hydrochloride Tablets— Resolved
• Methadone Injection— Resolved
• Methadone Oral Tablets and Liquid— Resolved
• Morphine PCA Syringes— Resolved
• Morphine Sulfate— No Longer Available
• Morphine Sulfate: Extended-Release Products
• Morphine Sulfate: Oral Concentrated Solution
• Oxycodone Combinations Capsules and Tablets
• Oxycodone Extended-Release Tablets— Resolved
• Oxycodone Tablets, Capsules, and Solutions
• Pentazocine / Naloxone Tablets
• Remifentanil Hydrochloride— Resolved
• Sufentanil Injection— Resolved

Updated

September 22, 2008; August 28, 2008; August 20, 2008; July 14, 2008; June 16, 2008; May 30, 2008, Copyright 2008, University of Utah, Drug Information Service.

Back to Drug Shortage Product Bulletins